Back | Next |
home / stock / mrtx / mrtx message board
Subject | By | Source | When |
---|---|---|---|
Three PII trials due to report out by | dmj3430 | investorshub | 09/18/2017 3:23:30 PM |
I like ur thinking !! $$$$$$ glta | omri | investorshub | 09/18/2017 12:38:58 PM |
Back to $38-$45 | biotechnician | investorshub | 09/18/2017 4:05:01 AM |
* * $MRTX Video Chart 09-15-17 * * | ClayTrader | investorshub | 09/15/2017 8:12:00 PM |
Then i guess they will Cover soon and | europtiger | investorshub | 09/15/2017 7:19:22 PM |
volume is beast and def suggest hold over | Tdash | investorshub | 09/15/2017 7:08:00 PM |
LMAO! > up 150% | crudeoil24 | investorshub | 09/15/2017 6:14:57 PM |
Hedge funds shorting!!!! Chasers will lose!!!! | Buckstopshere | investorshub | 09/15/2017 6:10:08 PM |
PT > hedge funds loading. | crudeoil24 | investorshub | 09/15/2017 6:02:01 PM |
Ur an ifioy | omri | investorshub | 09/15/2017 5:17:06 PM |
Dont b to sure ;) | europtiger | investorshub | 09/15/2017 4:41:11 PM |
It's over slow walk down | Buckstopshere | investorshub | 09/15/2017 4:37:18 PM |
I say closer to 13 as to 8 ;) | europtiger | investorshub | 09/15/2017 4:15:54 PM |
This will end up at 8.00!!! | Buckstopshere | investorshub | 09/15/2017 3:58:17 PM |
$MRTX was a $38 stock not too long ago | dmj3430 | investorshub | 09/15/2017 3:29:37 PM |
3 more clinical trial updates before year end | dmj3430 | investorshub | 09/15/2017 3:28:04 PM |
Amazing! | crudeoil24 | investorshub | 09/15/2017 3:07:16 PM |
13's cometh.. nice trading | Tdash | investorshub | 09/15/2017 3:01:41 PM |
Boomage!! $MRTX | Lone Wolf | investorshub | 09/15/2017 2:54:58 PM |
I'm in !!!!! Glta | omri | investorshub | 09/15/2017 2:50:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Mirati Therapeutics Inc. Company Name:
MRTX Stock Symbol:
NASDAQ Market:
Mirati Therapeutics Inc. Website:
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation PR Newswire SAN DIEGO and ZUG, Switzerland , Jan. 10, 2024 /PRNewswire/ -- Mirati The...
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...